Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Fleming

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Oncotarget|September 8, 2016
A novel method for RNA extraction from FFPE samples reveals significant differences in biomarker expression between orthotopic and subcutaneous pancreatic cancer patient-derived xenograftsMalachia Hoover, Yvess Adamian, Mark Brown, et al.
BMJ Open|June 5, 2025
Lymphatic mapping Of Oropharyngeal Cancer (LOOC): protocol for a phase II surgical imaging trial to evaluate contralateral drainage and occult metastasis in oropharyngeal cancerClare Schilling, Karl Payne, Simon Wan, et al.
Cancer Medicine|October 1, 2019
Clinical candidate and genistein analogue AXP107-11 has chemoenhancing functions in pancreatic adenocarcinoma through G protein-coupled estrogen receptor signalingFahmi Mesmar, Bingbing Dai, Ahmed Ibrahim, et al.
Advances in Radiation Oncology|November 9, 2017
Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPCLauren E Colbert, Shalini Moningi, Awalpreet Chadha, et al.
Cancer Research|June 12, 2021
Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK InhibitionLiang Yan, Bo Tu, Jun Yao, et al.
Abdominal Radiology (New York)|November 27, 2019
White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individualsNaveen M Kulkarni, Lorenzo Mannelli, Marc Zins, et al.
Cancer Control : Journal of the Moffitt Cancer Center|January 4, 2023
Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART)J M Bryant, Russell F Palm, Roberto Herrera, et al.
G3 (Bethesda, Md.)|December 1, 2022
A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasmsMargaret A Park, Thinzar Zaw, Sean J Yoder, et al.
Nature|January 19, 2017
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancerPrasenjit Dey, Joelle Baddour, Florian Muller, et al.
Gastrointestinal Endoscopy|November 22, 2025
Changes to Management Influenced by Next-Generation Sequencing of Pancreatic Duct Aspirates among Patients with Main Pancreatic Duct Dilation of Unclear Etiology: A Multi-Center Cohort StudyAlex R Jones, Amudhan Kannan, Dana Ley, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Oncotarget|September 8, 2016
A novel method for RNA extraction from FFPE samples reveals significant differences in biomarker expression between orthotopic and subcutaneous pancreatic cancer patient-derived xenograftsMalachia Hoover, Yvess Adamian, Mark Brown, et al.
BMJ Open|June 5, 2025
Lymphatic mapping Of Oropharyngeal Cancer (LOOC): protocol for a phase II surgical imaging trial to evaluate contralateral drainage and occult metastasis in oropharyngeal cancerClare Schilling, Karl Payne, Simon Wan, et al.
Cancer Medicine|October 1, 2019
Clinical candidate and genistein analogue AXP107-11 has chemoenhancing functions in pancreatic adenocarcinoma through G protein-coupled estrogen receptor signalingFahmi Mesmar, Bingbing Dai, Ahmed Ibrahim, et al.
Advances in Radiation Oncology|November 9, 2017
Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPCLauren E Colbert, Shalini Moningi, Awalpreet Chadha, et al.
Cancer Research|June 12, 2021
Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK InhibitionLiang Yan, Bo Tu, Jun Yao, et al.
Abdominal Radiology (New York)|November 27, 2019
White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individualsNaveen M Kulkarni, Lorenzo Mannelli, Marc Zins, et al.
Cancer Control : Journal of the Moffitt Cancer Center|January 4, 2023
Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART)J M Bryant, Russell F Palm, Roberto Herrera, et al.
G3 (Bethesda, Md.)|December 1, 2022
A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasmsMargaret A Park, Thinzar Zaw, Sean J Yoder, et al.
Nature|January 19, 2017
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancerPrasenjit Dey, Joelle Baddour, Florian Muller, et al.
Gastrointestinal Endoscopy|November 22, 2025
Changes to Management Influenced by Next-Generation Sequencing of Pancreatic Duct Aspirates among Patients with Main Pancreatic Duct Dilation of Unclear Etiology: A Multi-Center Cohort StudyAlex R Jones, Amudhan Kannan, Dana Ley, et al.
Pageof 5